Kraegen E W, Campbell L V, Chia Y O, Meler H, Lazarus L
Aust N Z J Med. 1977 Jun;7(3):280-6. doi: 10.1111/j.1445-5994.1977.tb03687.x.
Studies have been performed using an on-line computer system programmed for blood gucose control of insulin and dextrose infusion (artificial pancreas). The aim of these studies was to test performance of the artificial pancreas and to suggest directions for future optimisation. Blood glucose stabilisation studies of diabetic volunteers were extended throughout the day and included three main meals and light exercise periods. Monitoring of blood glucose profiles of the same diabetics after depot insulin were performed on a separate occasion for comparison. The presence of insulin antibodies did not impair operation of the artificial pancreas. Most of the insulin infused by the artificial pancreas was to initially correct hyperglycaemia with relatively little required to subsequently maintian euglycaemia. The afternoon intra-meal average infusion rate was 0-9 U/hr. It is suggested that correction of fasting hyperglycaemia and maintenance of euglycaemia in diabetics be treated as separate control problems for the artificial pancreas. The overall ability of the artificial pancreas to control blood glucose to a degree not attainable by conventional insulin therapy is confirmed, in this case under conditions which include patient activity.
已经使用一种为控制胰岛素和葡萄糖输注(人工胰腺)而编程的在线计算机系统进行了研究。这些研究的目的是测试人工胰腺的性能,并为未来的优化提供方向。糖尿病志愿者的血糖稳定研究持续了一整天,包括三餐和轻度运动时段。在另一个单独的时间对同一糖尿病患者注射长效胰岛素后的血糖曲线进行监测以作比较。胰岛素抗体的存在并不影响人工胰腺的运行。人工胰腺输注的大部分胰岛素最初用于纠正高血糖,随后维持血糖正常所需的量相对较少。下午餐间平均输注速率为0 - 9单位/小时。有人建议,对于人工胰腺而言,将糖尿病患者空腹高血糖的纠正和血糖正常的维持视为两个单独的控制问题。在包括患者活动的情况下,人工胰腺将血糖控制在传统胰岛素治疗无法达到的程度的总体能力得到了证实。